test44
https://www.cytel.com/blog/time-check-developing-new-therapeutics
April 5, 2022
Hello! I’m delighted to pen my inaugural blog post here as Cytel’s Chief Medical Officer. In this series, we’ll explore..
Read article
test44
https://www.cytel.com/blog/innovations-in-oncology-trial-design-development-webinar-series
May 12, 2020
In our previous blog, “Remote Working Arrangement – How to get it right?”, we talked about how the need for social..
Read article
test44
https://www.cytel.com/blog/covid-19-trials-designs-and-tools-for-promising-results-panel-discussion
May 7, 2020
An extraordinary amount of global research is underway as the COVID-19 pandemic continues to evolve and spread..
Read article
test44
https://www.cytel.com/blog/webinar-a-clinicians-perspective-on-cancer-drugs-development
May 5, 2020
Cytel's team of oncology trial design and advanced analytics experts are hosting a series of complimentary webinars..
Read article
test44
https://www.cytel.com/blog/a-clinicians-perspective-on-cancer-drugs-development-an-interview-with-martin-fey
April 23, 2020
Cytel is hosting a webinar, “A Clinician’s Perspective on Cancer Drugs Development”, on April 28, 2020. Our speaker,..
Read article
test44
https://www.cytel.com/blog/2010vs2018-guidance-adaptive-designs
test44
https://www.cytel.com/blog/statistical-methods-challenges-rare-disease-development
February 28, 2019
In honor of Rare Disease Day 2019 we share a new Cytel podcast featuring Cytel Strategic Consultant Ursula Garczarek..
Read article
test44
https://www.cytel.com/blog/phase-1-development-rawat-interview
January 10, 2019
Nand Kishore Rawat is a Director and Head, Early Phase Biostatistics based in the King of Prussia, PA Cytel office...
Read article
test44
https://www.cytel.com/blog/creating-a-common-language-statistician-medical
December 5, 2018
In this blog, Paul Terrill, Director of Strategic Consulting at Cytel outlines his blueprint for ensuring smooth..
Read article
